HEADER RIBOSOME 17-SEP-01 1K00 OBSLTE 08-MAR-02 1K00 1J5A TITLE STRUCTURAL BASIS FOR THE INTERACTION OF ANTIBIOTICS WITH TITLE 2 THE PEPTIDYL TRANSFERASE CENTER IN EUBACTERIA COMPND MOL_ID: 1; COMPND 2 MOLECULE: 23S RRNA; COMPND 3 CHAIN: A; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: RIBOSOMAL PROTEIN L4; COMPND 6 CHAIN: K; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: RIBOSOMAL PROTEIN L22; COMPND 9 CHAIN: L; COMPND 10 MOL_ID: 4; COMPND 11 MOLECULE: RIBOSOMAL PROTEIN L32; COMPND 12 CHAIN: M; COMPND 13 SYNONYM: 50S RIBOSOMAL PROTEIN L32 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DEINOCOCCUS RADIODURANS; SOURCE 3 ORGANISM_COMMON: BACTERIA; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: DEINOCOCCUS RADIODURANS; SOURCE 6 ORGANISM_COMMON: BACTERIA; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: DEINOCOCCUS RADIODURANS; SOURCE 9 ORGANISM_COMMON: BACTERIA; SOURCE 10 MOL_ID: 4; SOURCE 11 ORGANISM_SCIENTIFIC: DEINOCOCCUS RADIODURANS; SOURCE 12 ORGANISM_COMMON: BACTERIA KEYWDS RIBOSOME, 50S, 23S, 5S, ANTIBIOTICS, CLARITHROMYCIN, KEYWDS 2 PEPTIDYL TRANSFERASE CENTER EXPDTA X-RAY DIFFRACTION AUTHOR F.SCHLUENZEN,R.ZARIVACH,J.HARMS,A.BASHAN,A.TOCILJ, AUTHOR 2 R.ALBRECHT,A.YONATH,F.FRANCESCHI REVDAT 2 08-MAR-02 1K00 1 OBSLTE REVDAT 1 26-OCT-01 1K00 0 JRNL AUTH F.SCHLUENZEN,R.ZARIVACH,J.HARMS,A.BASHAN,A.TOCILJ, JRNL AUTH 2 R.ALBRECHT,A.YONATH,F.FRANCESCHI JRNL TITL STRUCTURAL BASIS FOR THE INTERACTION OF JRNL TITL 2 ANTIBIOTICS WITH THE PEPTIDYL TRANSFERASE CENTRE JRNL TITL 3 IN EUBACTERIA JRNL REF NATURE V. 413 814 2001 JRNL REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS,REFMAC REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 260808 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.273 REMARK 3 FREE R VALUE : 0.323 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 12257 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 385 REMARK 3 NUCLEIC ACID ATOMS : 59532 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.003 REMARK 3 BOND ANGLES (DEGREES) : 0.67 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE COORDINATES OF FOUR CHAINS OF REMARK 3 THE 50S SUBUNIT AND CLARITHROMYCIN WERE DEPOSITED. THE NUMBER REMARK 3 OF NON-HYDROGEN ATOMS USED IN REFINEMENT IS MORE THAN REMARK 3 SPECIFIED IN REMARK 3: 26069 PROTEIN ATOMS, 62115 NUCLEIC ACID REMARK 3 ATOMS, AND 123 HETEROGEN ATOMS WERE USED IN REFINEMENT. REMARK 4 REMARK 4 1K00 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY THE NUCLEIC ACID DATABASE REMARK 100 ON 22-OCT-2001. REMARK 100 THE NDB ID CODE IS RR0040. REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-2001 REMARK 200 TEMPERATURE (KELVIN) : 90.0 REMARK 200 PH : 7.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 260808 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ETHANOL, DIMETHYLHEXANEDIOL, MGCL2, REMARK 280 KCL, HEPES, NH4CL, PH 7.8, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 1/2+X,1/2+Y,1/2+Z REMARK 290 6555 1/2-X,1/2-Y,1/2+Z REMARK 290 7555 1/2-X,1/2+Y,1/2-Z REMARK 290 8555 1/2+X,1/2-Y,1/2-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 84.95000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 206.35000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 348.50000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 84.95000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 206.35000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 348.50000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 84.95000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 206.35000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 348.50000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 84.95000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 206.35000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 348.50000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, K, L, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 A A 249 REMARK 465 C A 250 REMARK 465 C A 251 REMARK 465 G A 252 REMARK 465 A A 253 REMARK 465 A A 254 REMARK 465 A A 255 REMARK 465 C A 256 REMARK 465 G A 257 REMARK 465 C A 258 REMARK 465 U A 259 REMARK 465 U A 260 REMARK 465 G A 261 REMARK 465 C A 262 REMARK 465 G A 263 REMARK 465 U A 264 REMARK 465 U A 265 REMARK 465 U A 266 REMARK 465 C A 267 REMARK 465 G A 268 REMARK 465 G A 269 REMARK 465 G A 270 REMARK 465 G A 271 REMARK 465 U A 272 REMARK 465 U A 273 REMARK 465 G A 274 REMARK 465 U A 275 REMARK 465 A A 276 REMARK 465 G A 277 REMARK 465 G A 278 REMARK 465 A A 279 REMARK 465 C A 280 REMARK 465 C A 281 REMARK 465 A A 282 REMARK 465 G A 283 REMARK 465 U A 284 REMARK 465 U A 285 REMARK 465 U A 286 REMARK 465 U A 287 REMARK 465 U A 288 REMARK 465 A A 289 REMARK 465 C A 374 REMARK 465 U A 375 REMARK 465 G A 376 REMARK 465 G A 377 REMARK 465 C A 378 REMARK 465 A A 379 REMARK 465 C A 380 REMARK 465 C A 381 REMARK 465 U A 382 REMARK 465 G A 383 REMARK 465 G A 893 REMARK 465 G A 894 REMARK 465 G A 895 REMARK 465 G A 896 REMARK 465 C A 897 REMARK 465 C A 898 REMARK 465 U A 899 REMARK 465 A A 900 REMARK 465 C A 901 REMARK 465 C A 902 REMARK 465 A A 903 REMARK 465 G A 904 REMARK 465 C A 905 REMARK 465 U A 906 REMARK 465 U A 907 REMARK 465 A A 908 REMARK 465 G A 2098 REMARK 465 G A 2099 REMARK 465 A A 2100 REMARK 465 U A 2101 REMARK 465 A A 2102 REMARK 465 C A 2111 REMARK 465 C A 2112 REMARK 465 U A 2113 REMARK 465 G A 2114 REMARK 465 C A 2115 REMARK 465 G A 2116 REMARK 465 U A 2126 REMARK 465 U A 2127 REMARK 465 U A 2128 REMARK 465 U A 2129 REMARK 465 G A 2130 REMARK 465 G A 2131 REMARK 465 A A 2141 REMARK 465 G A 2142 REMARK 465 G A 2143 REMARK 465 C A 2144 REMARK 465 A A 2145 REMARK 465 A A 2146 REMARK 465 C A 2147 REMARK 465 G A 2148 REMARK 465 G A 2149 REMARK 465 U A 2150 REMARK 465 G A 2151 REMARK 465 A A 2152 REMARK 465 A A 2153 REMARK 465 A A 2154 REMARK 465 U A 2155 REMARK 465 A A 2156 REMARK 465 U A 2775 REMARK 465 U A 2776 REMARK 465 A A 2777 REMARK 465 C A 2878 REMARK 465 U A 2879 REMARK 465 C A 2880 REMARK 465 MET K 1 REMARK 465 GLU K 199 REMARK 465 ALA K 200 REMARK 465 GLY K 201 REMARK 465 GLU K 202 REMARK 465 GLU K 203 REMARK 465 GLN K 204 REMARK 465 GLN K 205 REMARK 465 MET L 1 REMARK 465 THR L 2 REMARK 465 ALA L 3 REMARK 465 PRO L 4 REMARK 465 MET M 1 REMARK 465 VAL M 60 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O2* G A 2324 O2P A A 2325 2.08 REMARK 500 O2* A A 777 O1P G A 778 2.18 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JZX RELATED DB: PDB REMARK 900 50S RIBOSOMAL SUBUNIT COMPLEXED WITH CLINDAMYCIN. REMARK 900 RELATED ID: 1JZY RELATED DB: PDB REMARK 900 50S RIBOSOMAL SUBUNIT COMPLEXED WITH ERYTHROMYCIN. REMARK 900 RELATED ID: 1JZZ RELATED DB: PDB REMARK 900 50S RIBOSOMAL SUBUNIT COMPLEXED WITH ROXITHROMYCIN. REMARK 900 RELATED ID: 1K01 RELATED DB: PDB REMARK 900 50S RIBOSOMAL SUBUNIT COMPLEXED WITH CHLORAMPHENICOL. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE DATABASE REFERENCE FOR THIS ENTRY IS REMARK 999 GENBANK GI 15805042 FROM 2587937 TO 2585058. THIS REMARK 999 SEQUENCE LISTS A Y AT POSITION 2586412 BECAUSE REMARK 999 EITHER C OR U CAN BE PRESENT. U IS PRESENT IN REMARK 999 THIS STRUCTURE. DBREF 1K00 A 1 2880 GB 15805042 NC_001263 DBREF 1K00 K 1 205 GB 6457986 AAF09893 1 205 DBREF 1K00 L 1 134 GB 6457990 AAF09897 1 134 DBREF 1K00 M 1 60 UNP P49228 RL32_DEIRA 1 60 SEQADV 1K00 U A 1526 GB 15805042 Y SEE REMARK 999 SEQRES 1 A 2880 G G U C A A G A U A G U A SEQRES 2 A 2880 A G G G U C C A C G G U G SEQRES 3 A 2880 G A U G C C C U G G C G C SEQRES 4 A 2880 U G G A G C C G A U G A A SEQRES 5 A 2880 G G A C G C G A U U A C C SEQRES 6 A 2880 U G C G A A A A G C C C C SEQRES 7 A 2880 G A C G A G C U G G A G A SEQRES 8 A 2880 U A C G C U U U G A C U C SEQRES 9 A 2880 G G G G A U G U C C G A A SEQRES 10 A 2880 U G G G G A A A C C C A C SEQRES 11 A 2880 C U C G U A A G A G G U A SEQRES 12 A 2880 U C C G C A A G G A U G G SEQRES 13 A 2880 G A A C U C A G G G A A C SEQRES 14 A 2880 U G A A A C A U C U C A G SEQRES 15 A 2880 U A C C U G A A G G A G A SEQRES 16 A 2880 A G A A A G A G A A U U C SEQRES 17 A 2880 G A U U C C G U U A G U A SEQRES 18 A 2880 G C G G C G A G C G A A C SEQRES 19 A 2880 C C G G A U C A G C C C A SEQRES 20 A 2880 A A C C G A A A C G C U U SEQRES 21 A 2880 G C G U U U C G G G G U U SEQRES 22 A 2880 G U A G G A C C A G U U U SEQRES 23 A 2880 U U A A G A U U C A A C C SEQRES 24 A 2880 C C U C A A G C C G A A G SEQRES 25 A 2880 U G G C U G G A A A G C U SEQRES 26 A 2880 A C A C C U C A G A A G G SEQRES 27 A 2880 U G A G A G U C C U G U A SEQRES 28 A 2880 G G C G A A C G A G C G G SEQRES 29 A 2880 U U G A C U G U A C U G G SEQRES 30 A 2880 C A C C U G A G U A G G U SEQRES 31 A 2880 C G U U G U U C G U G A A SEQRES 32 A 2880 A C G A U G A C U G A A U SEQRES 33 A 2880 C C G C G C G G A C C A C SEQRES 34 A 2880 C G C G C A A G G C U A A SEQRES 35 A 2880 A U A C U C C C A G U G A SEQRES 36 A 2880 C C G A U A G C G C A U A SEQRES 37 A 2880 G U A C C G U G A G G G A SEQRES 38 A 2880 A A G G U G A A A A G A A SEQRES 39 A 2880 C C C C G G G A G G G G A SEQRES 40 A 2880 G U G A A A G A G A A C C SEQRES 41 A 2880 U G A A A C C G U G G A C SEQRES 42 A 2880 U U A C A A G C A G U C A SEQRES 43 A 2880 U G G C A C C U U A U G C SEQRES 44 A 2880 G U G U U A U G G C G U G SEQRES 45 A 2880 C C U A U U G A A G C A U SEQRES 46 A 2880 G A G C C G G C G A C U U SEQRES 47 A 2880 A G A C C U G A C G U G C SEQRES 48 A 2880 G A G C U U A A G U U G A SEQRES 49 A 2880 A A A A C G G A G G C G G SEQRES 50 A 2880 A G C G A A A G C G A G U SEQRES 51 A 2880 C C G A A U A G G G C G G SEQRES 52 A 2880 C A U U A G U A C G U C G SEQRES 53 A 2880 G G C U A G A C U C G A A SEQRES 54 A 2880 A C C A G G U G A G C U A SEQRES 55 A 2880 A G C A U G A C C A G G U SEQRES 56 A 2880 U G A A A C C C C C G U G SEQRES 57 A 2880 A C A G G G G G C G G A G SEQRES 58 A 2880 G A C C G A A C C G G U G SEQRES 59 A 2880 C C U G C U G A A A C A G SEQRES 60 A 2880 U C U C G G A U G A G U U SEQRES 61 A 2880 G U G U U U A G G A G U G SEQRES 62 A 2880 A A A A G C U A A C C G A SEQRES 63 A 2880 A C C U G G A G A U A G C SEQRES 64 A 2880 U A G U U C U C C C C G A SEQRES 65 A 2880 A A U G U A U U G A G G U SEQRES 66 A 2880 A C A G C C U C G G A U G SEQRES 67 A 2880 U U G A C C A U G U C C U SEQRES 68 A 2880 G U A G A G C A C U C A C SEQRES 69 A 2880 A A G G C U A G G G G G C SEQRES 70 A 2880 C U A C C A G C U U A C C SEQRES 71 A 2880 A A A C C U U A U G A A A SEQRES 72 A 2880 C U C C G A A G G G G C A SEQRES 73 A 2880 C G C G U U U A G U C C G SEQRES 74 A 2880 G G A G U G A G G C U G C SEQRES 75 A 2880 G A G A G C U A A C U U C SEQRES 76 A 2880 C G U A G C C G A G A G G SEQRES 77 A 2880 G A A A C A A C C C A G A SEQRES 78 A 2880 C C A U C A G C U A A G G SEQRES 79 A 2880 U C C C U A A A U G A U C SEQRES 80 A 2880 G C U C A G U G G U U A A SEQRES 81 A 2880 G G A U G U G U C G U C G SEQRES 82 A 2880 C A U A G A C A G C C A G SEQRES 83 A 2880 G A G G U U G G C U U A G SEQRES 84 A 2880 A A G C A G C C A C C C U SEQRES 85 A 2880 U C A A A G A G U G C G U SEQRES 86 A 2880 A A U A G C U C A C U G G SEQRES 87 A 2880 U C G A G U G A C G A U G SEQRES 88 A 2880 C G C C G A A A A U G A U SEQRES 89 A 2880 C G G G G C U C A A G U G SEQRES 90 A 2880 A U C U A C C G A A G C U SEQRES 91 A 2880 A U G G A U U C A A C U C SEQRES 92 A 2880 G C G A A G C G A G U U G SEQRES 93 A 2880 U C U G G U A G G G G A G SEQRES 94 A 2880 C G U U C A G U C C G C G SEQRES 95 A 2880 G A G A A G C C A U A C C SEQRES 96 A 2880 G G A A G G A G U G G U G SEQRES 97 A 2880 G A G C C G A C U G A A G SEQRES 98 A 2880 U G C G G A U G C C G G C SEQRES 99 A 2880 A U G A G U A A C G A U A SEQRES 10 A 2880 A A A G A A G U G A G A A SEQRES 10 A 2880 U C U U C U U C G C C G U SEQRES 10 A 2880 A A G G A C A A G G G U U SEQRES 10 A 2880 C C U G G G G A A G G G U SEQRES 10 A 2880 C G U C C G C C C A G G G SEQRES 10 A 2880 A A A G U C G G G A C C U SEQRES 10 A 2880 A A G G U G A G G C C G A SEQRES 10 A 2880 A C G G C G C A G C C G A SEQRES 10 A 2880 U G G A C A G C A G G U C SEQRES 10 A 2880 A A G A U U C C U G C A C SEQRES 11 A 2880 C G A U C A U G U G G A G SEQRES 11 A 2880 U G A U G G A G G G A C G SEQRES 11 A 2880 C A U U A C G C U A U C C SEQRES 11 A 2880 A A U G C C A A G C U A U SEQRES 11 A 2880 G G C U A U G C U G G U U SEQRES 11 A 2880 G G U A C G C U C A A G G SEQRES 11 A 2880 G C G A U C G G G U C A G SEQRES 11 A 2880 A A A A U C U A C C G G U SEQRES 11 A 2880 C A C A U G C C U C A G A SEQRES 11 A 2880 C G U A U C G G G A G C U SEQRES 12 A 2880 U C C U C G G A A G C G A SEQRES 12 A 2880 A G U U G G A A A C G C G SEQRES 12 A 2880 A C G G U G C C A A G A A SEQRES 12 A 2880 A A G C U U C U A A A C G SEQRES 12 A 2880 U U G A A A C A U G A U U SEQRES 12 A 2880 G C C C G U A C C G C A A SEQRES 12 A 2880 A C C G A C A C A G G U G SEQRES 12 A 2880 U C C G A G U G U C A A U SEQRES 12 A 2880 G C A C U A A G G C G C G SEQRES 12 A 2880 C G A G A G A A C C C U C SEQRES 13 A 2880 G U U A A G G A A C U U U SEQRES 13 A 2880 G C A A U C U C A C C C C SEQRES 13 A 2880 G U A A C U U C G G A A G SEQRES 13 A 2880 A A G G G G U C C C C A C SEQRES 13 A 2880 G C U U C G C G U G G G G SEQRES 13 A 2880 C G C A G U G A A U A G G SEQRES 13 A 2880 C C C A G G C G A C U G U SEQRES 13 A 2880 U U A C C A A A A U C A C SEQRES 13 A 2880 A G C A C U C U G C C A A SEQRES 13 A 2880 C A C G A A C A G U G G A SEQRES 14 A 2880 C G U A U A G G G U G U G SEQRES 14 A 2880 A C G C C U G C C C G G U SEQRES 14 A 2880 G C C G G A A G G U C A A SEQRES 14 A 2880 G U G G A G C G G U G C A SEQRES 14 A 2880 A G C U G C G A A A U G A SEQRES 14 A 2880 A G C C C C G G U G A A C SEQRES 14 A 2880 G G C G G C C G U A A C U SEQRES 14 A 2880 A U A A C G G U C C U A A SEQRES 14 A 2880 G G U A G C G A A A U U C SEQRES 14 A 2880 C U U G U C G G G U A A G SEQRES 15 A 2880 U U C C G A C C U G C A C SEQRES 15 A 2880 G A A A G G C G U A A C G SEQRES 15 A 2880 A U C U G G G C G C U G U SEQRES 15 A 2880 C U C A A C G A G G G A C SEQRES 15 A 2880 U C G G U G A A A U U G A SEQRES 15 A 2880 A U U G G C U G U A A A G SEQRES 15 A 2880 A U G C G G C C U A C C C SEQRES 15 A 2880 G U A G C A G G A C G A A SEQRES 15 A 2880 A A G A C C C C G U G G A SEQRES 15 A 2880 G C U U U A C U A U A G U SEQRES 16 A 2880 C U G G C A U U G G G A U SEQRES 16 A 2880 U C G G G U U U C U C U G SEQRES 16 A 2880 C G U A G G A U A G G U G SEQRES 16 A 2880 G G A G C C U G C G A A A SEQRES 16 A 2880 C U G G C C U U U U G G G SEQRES 16 A 2880 G U C G G U G G A G G C A SEQRES 16 A 2880 A C G G U G A A A U A C C SEQRES 16 A 2880 A C C C U G A G A A A C U SEQRES 16 A 2880 U G G A U U U C U A A C C SEQRES 16 A 2880 U G A A A A A U C A C U U SEQRES 17 A 2880 U C G G G G A C C G U G C SEQRES 17 A 2880 U U G G C G G G U A G U U SEQRES 17 A 2880 U G A C U G G G G C G G U SEQRES 17 A 2880 C G C C U C C C A A A A U SEQRES 17 A 2880 G U A A C G G A G G C G C SEQRES 17 A 2880 C C A A A G G U C A C C U SEQRES 17 A 2880 C A A G A C G G U U G G A SEQRES 17 A 2880 A A U C G U C U G U A G A SEQRES 17 A 2880 G C G C A A A G G U A G A SEQRES 17 A 2880 A G G U G G C U U G A C U SEQRES 18 A 2880 G C G A G A C U G A C A C SEQRES 18 A 2880 G U C G A G C A G G G A G SEQRES 18 A 2880 G A A A C U C G G G C U U SEQRES 18 A 2880 A G U G A A C C G G U G G SEQRES 18 A 2880 U A C C G U G U G G A A G SEQRES 18 A 2880 G G C C A U C G A U C A A SEQRES 18 A 2880 C G G A U A A A A G U U A SEQRES 18 A 2880 C C C C G G G G A U A A C SEQRES 18 A 2880 A G G C U G A U C U C C C SEQRES 18 A 2880 C C G A G A G U C C A U A SEQRES 19 A 2880 U C G G C G G G G A G G U SEQRES 19 A 2880 U U G G C A C C U C G A U SEQRES 19 A 2880 G U C G G C U C G U C G C SEQRES 19 A 2880 A U C C U G G G G C U G A SEQRES 19 A 2880 A G A A G G U C C C A A G SEQRES 19 A 2880 G G U U G G G C U G U U C SEQRES 19 A 2880 G C C C A U U A A A G C G SEQRES 19 A 2880 G C A C G C G A G C U G G SEQRES 19 A 2880 G U U C A G A A C G U C G SEQRES 19 A 2880 U G A G A C A G U U C G G SEQRES 20 A 2880 U C U C U A U C C G C U A SEQRES 20 A 2880 C G G G C G C A G G A G A SEQRES 20 A 2880 A U U G A G G G G A G U U SEQRES 20 A 2880 G C U C C U A G U A C G A SEQRES 20 A 2880 G A G G A C C G G A G U G SEQRES 20 A 2880 A A C G G A C C G C U G G SEQRES 20 A 2880 U C U C C C U G C U G U C SEQRES 20 A 2880 G U A C C A A C G G C A C SEQRES 20 A 2880 A U G C A G G G U A G C U SEQRES 20 A 2880 A U G U C C G G A A C G G SEQRES 21 A 2880 A U A A C C G C U G A A A SEQRES 21 A 2880 G C A U C U A A G C G G G SEQRES 21 A 2880 A A G C C A G C C C C A A SEQRES 21 A 2880 G A U G A G U U C U C C C SEQRES 21 A 2880 A C U G U U U A U C A G G SEQRES 21 A 2880 U A A G A C U C C C G G A SEQRES 21 A 2880 A G A C C A C C G G G U U SEQRES 21 A 2880 A A G A G G C C A G G C G SEQRES 21 A 2880 U G C A C G C A U A G C A SEQRES 21 A 2880 A U G U G U U C A G C G G SEQRES 22 A 2880 A C U G G U G C U C A U C SEQRES 22 A 2880 A G U C G A G G U C U U G SEQRES 22 A 2880 A C C A C U C SEQRES 1 K 205 MET ALA GLN ILE ASN VAL ILE GLY GLN ASN GLY GLY ARG SEQRES 2 K 205 THR ILE GLU LEU PRO LEU PRO GLU VAL ASN SER GLY VAL SEQRES 3 K 205 LEU HIS GLU VAL VAL THR TRP GLN LEU ALA SER ARG ARG SEQRES 4 K 205 ARG GLY THR ALA SER THR ARG THR ARG ALA GLN VAL SER SEQRES 5 K 205 LYS THR GLY ARG LYS MET TYR GLY GLN LYS GLY THR GLY SEQRES 6 K 205 ASN ALA ARG HIS GLY ASP ARG SER VAL PRO THR PHE VAL SEQRES 7 K 205 GLY GLY GLY VAL ALA PHE GLY PRO LYS PRO ARG SER TYR SEQRES 8 K 205 ASP TYR THR LEU PRO ARG GLN VAL ARG GLN LEU GLY LEU SEQRES 9 K 205 ALA MET ALA ILE ALA SER ARG GLN GLU GLY GLY LYS LEU SEQRES 10 K 205 VAL ALA VAL ASP GLY PHE ASP ILE ALA ASP ALA LYS THR SEQRES 11 K 205 LYS ASN PHE ILE SER TRP ALA LYS GLN ASN GLY LEU ASP SEQRES 12 K 205 GLY THR GLU LYS VAL LEU LEU VAL THR ASP ASP GLU ASN SEQRES 13 K 205 THR ARG ARG ALA ALA ARG ASN VAL SER TRP VAL SER VAL SEQRES 14 K 205 LEU PRO VAL ALA GLY VAL ASN VAL TYR ASP ILE LEU ARG SEQRES 15 K 205 HIS ASP ARG LEU VAL ILE ASP ALA ALA ALA LEU GLU ILE SEQRES 16 K 205 VAL GLU GLU GLU ALA GLY GLU GLU GLN GLN SEQRES 1 L 134 MET THR ALA PRO GLU GLN THR PHE ARG ASN LYS LYS GLN SEQRES 2 L 134 ARG LYS GLN GLN VAL LYS LEU ARG LYS PRO GLY PHE ALA SEQRES 3 L 134 VAL ALA LYS TYR VAL ARG MET SER PRO ARG LYS VAL ARG SEQRES 4 L 134 LEU VAL VAL ASP VAL ILE ARG GLY LYS SER VAL GLN ASP SEQRES 5 L 134 ALA GLU ASP LEU LEU ARG PHE ILE PRO ARG SER ALA SER SEQRES 6 L 134 GLU PRO VAL ALA LYS VAL LEU ASN SER ALA LYS ALA ASN SEQRES 7 L 134 ALA LEU HIS ASN ASP GLU MET LEU GLU ASP ARG LEU PHE SEQRES 8 L 134 VAL LYS GLU ALA TYR VAL ASP ALA GLY PRO THR LEU LYS SEQRES 9 L 134 ARG LEU ILE PRO ARG ALA ARG GLY SER ALA ASN ILE ILE SEQRES 10 L 134 LYS LYS ARG THR SER HIS ILE THR ILE ILE VAL ALA GLU SEQRES 11 L 134 LYS GLY ASN LYS SEQRES 1 M 60 MET ALA LYS HIS PRO VAL PRO LYS LYS LYS THR SER LYS SEQRES 2 M 60 SER LYS ARG ASP MET ARG ARG SER HIS HIS ALA LEU THR SEQRES 3 M 60 ALA PRO ASN LEU THR GLU CYS PRO GLN CYS HIS GLY LYS SEQRES 4 M 60 LYS LEU SER HIS HIS ILE CYS PRO ASN CYS GLY TYR TYR SEQRES 5 M 60 ASP GLY ARG GLN VAL LEU ALA VAL HET CTY 1 51 HET MG 33 1 HET MG 101 1 HETNAM CTY CLARITHROMYCIN HETNAM MG MAGNESIUM ION FORMUL 5 CTY C38 H69 N O13 FORMUL 6 MG 2(MG 2+) CRYST1 169.900 412.700 697.000 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005886 0.000000 0.000000 0.00000 SCALE2 0.000000 0.002423 0.000000 0.00000 SCALE3 0.000000 0.000000 0.001435 0.00000